年単位の研究成果
Fingerprint Takeshi Suzukiが取り組む研究トピックをご確認ください。これらのトピックラベルは、この人物の研究に基づいています。これらを共に使用することで、固有の認識が可能になります。
- 3 同様のプロファイル
Acetylcholine
Medicine & Life Sciences
Inbred SHR Rats
Medicine & Life Sciences
tetrandrine
Medicine & Life Sciences
Japan
Medicine & Life Sciences
Antihypertensive Agents
Medicine & Life Sciences
Blood Pressure
Medicine & Life Sciences
Stroke
Medicine & Life Sciences
Cholinergic Agents
Medicine & Life Sciences
ネットワーク
最近の共同研究。丸をクリックして詳細を確認しましょう。
研究成果 1987 2019
- 1635 引用
- 23 h指数
- 78 Article
Analyzing Upward Deviation of Actual vs Predicted Drug Sales in Japan for a Reasonable Drug-Pricing Policy
Shibata, S., Fukumoto, D., Suzuki, T. & Ozaki, K., 2019 1 1, (Accepted/In press) ： : Therapeutic Innovation and Regulatory Science.研究成果: Article
Japan
Costs and Cost Analysis
Pharmaceutical Preparations
Health Expenditures
Drug Costs
1
引用
(Scopus)
Anticancer Drug Prescription Patterns in Japan: Future Directions in Cancer Therapy
Shibata, S., Matsushita, M., Saito, Y. & Suzuki, T., 2018 11 1, ： : Therapeutic Innovation and Regulatory Science. 52, 6, p. 718-723 6 p.研究成果: Article
Drug Prescriptions
Japan
Pharmaceutical Preparations
Neoplasms
Health Expenditures
An empirical study of the prescription pattern of drugs for hematological malignancies in Japan from 2010-2014
Shibata, S., Wayama, Y., Tsuyuki, A., Matsushita, M., Chiba, K., Matsuki, E., Okamoto, S. & Suzuki, T., 2017, ： : Biological and Pharmaceutical Bulletin. 40, 6, p. 894-901 8 p.研究成果: Article
Prescription Drugs
Hematologic Neoplasms
Japan
Pharmaceutical Preparations
Pharmaceutical Databases
1
引用
(Scopus)
CXorf48 is a potential therapeutic target for achieving treatment-free remission in CML patients
Matsushita, M., Ozawa, K., Suzuki, T., Nakamura, M., Nakano, N., Kanchi, S., Ichikawa, D., Matsuki, E., Sakurai, M., Karigane, D., Kasahara, H., Tsukamoto, N., Shimizu, T., Mori, T., Nakajima, H., Okamoto, S., Kawakami, Y. & Hattori, Y., 2017 9 1, ： : Blood Cancer Journal. 7, 9, e601.研究成果: Article
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
Protein-Tyrosine Kinases
Stem Cells
Therapeutics
T-Lymphocytes
Drugs Targeted for Price Cutting in Japan: The Case of Price Revisions Based on the Divergence of Official Versus Delivery Prices
Fukumoto, D., Tsuyuki, A. & Suzuki, T., 2017 9 1, ： : Therapeutic Innovation and Regulatory Science. 51, 5, p. 597-603 7 p.研究成果: Article
Japan
Pharmaceutical Preparations
Generic Drugs
Linear Models